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Reply
To the editor:
We thank Dr Hughes for his interest in our article reporting factors influencing Raynaud’s 
phenomenon (RP) symptom reporting in patients with systemic sclerosis (SSc) [1]. We presented 
data demonstrating differences in Raynaud’s symptom reporting using the Raynaud’s Condition 
Score (RCS) diary depending on season of enrolment[2]. A weaker than expected relationship 
between external temperature (using Meterological Office data) and contemporaneous collection 
of the RCS diary (Spearman rho ~-0.25) suggests other factors, beyond cold exposure, may 
contribute to Raynaud’s burden in SSc [2]. Dr Hughes has presented an analysis of the impact of 
season on Raynaud’s by evaluiating the influence of seasonal variation on internet searches 
utilizing the term Raynaud’s phenomenon. Consistent with an anticipated relationship between 
cold exposure and Raynaud’s symptoms, a clear pattern emerges highlighting increasing health-
seeking internet search activity for Raynaud’s during the colder months, with troughs during 
warmer seasons. An evaluation of mean monthly UK temperatures over the same period of 
analysis suggests seasonal factors beyond external temperature may contribute to information-
seeking behaviour for Raynaud’s symptoms. The chart of UK internet search activity for 
Raynaud’s presented by Dr Hughes revealed a pronounced spike during January 2008 (>70 ‘peak 
popularity’ units) compared to January 2010 (<40 units), despite average UK temperatures within 
those months being 5.3°C and 0.9°C respectively (Figure 1)[3]. Seasonal factors beyond external 
temperature may therefore contribute to variation in RP symptoms (and information-seeking 
internet searches); perhaps including humidity, precipitation and wind-chill. A range of factors 
beyond cold exposure have been associated with precipitating RP symptoms in SSc; particularly 
situations associated with temperature change e.g. entering air-conditioned premises, 
damp/water exposure, chilled food aisles in grocery stores and emotional stress [4, 5]. Extreme 
cold can lead to reluctance to go outdoors and increased reliance upon others, which could 
mitigate RP symptoms (at the expense of reduced social participation) [4].
It is expected that the majority of the internet searches presented by Dr Hughes will have been 
made by people affected by ‘primary RP’. Once again, there are expected (and unexpected) 
associations between local climate and Raynaud’s symptoms. There is marked geographic 
variation in prevalence estimates of primary RP across different countries, ranging from 2.1% of 
females in Japan to 22.4% in Scandinavia [6]. Such variation is typically attributed to differences 
in climate and considered in the context of digital vasoconstriction representing an important, and 
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entirely appropriate, thermoregulatory response to cold exposure. Such observations have led 
people to question the very existence of “primary Raynaud’s”; proposing instead that ‘these are 
healthy people whose cold and colourful hands are more obvious (and) occasionally more 
troublesome, than that of their peers’[7]. Additional cultural, social (and possibly ethnic) factors 
may also influence the relationship between climate and Raynaud’s symptoms. Community-
based studies in South Carolina and 4 geographic regions of France supported a direct 
relationship between local climate and RP prevalence, but this relationship was challenged by the 
subsequent identification of a comparatively lower prevalence of RP symptoms in Southern 
Estonia in spite of its colder winters [7-9]. Cultural, ethnic and clinical phenotypic factors appear 
to contribute to geographic variation in RP symptom burden in SSc. Data from separate clinical 
trials of tadalafil for SSc-RP that each enrolled patients over Winter identified a higher frequency 
and burden of RP symptoms in patients enrolled in Lucknow, India (mean 3.5 Raynaud’s 
attacks/day and mean daily RCS of 5.28/10) compared to Ann Arbor, Michigan (2.9 attacks/day 
and mean RCS 3.76/10), despite an expected difference in mean daily temperature of ~20°C 
(+16°C to -4°C) across the 2 regions [10].
So what are the implications of such observations for clinical practice and therapeutic trials of 
RP? The relationship between climate and geographic variation in Raynaud’s prevalence 
highlights the need to emphasize the importance of maintaining core temperature when 
counselling patients on RP management. Reassuring patients with primary RP that digital 
vasoconstriction is an important physiological response and that, for many, RP symptoms 
represent an exaggerated healthy state that, whilst intrusive, are not dangerous may allay health 
anxiety. Therapeutic trials of Raynaud’s have traditionally enrolled patients over Winter months 
but 12-16 week assessments of primary endpoints risk seasonal variation in weather influencing 
outcome assessments; a somewhat overlooked factor that may contribute to the high placebo-
response typically observed in RP clinical trials [10]. We agree with Dr Hughes’ suggestion that 
shorter-term clinical trials over 1-2 weeks are preferable, but only if outcome measures can be 
validated to facilitate this (e.g. objective microvascular imaging or retrospective self-administered 
patient-reported outcome instruments) [10]. Weather (certainly across much of Europe and North 
America) can be fickle, with frequent swift and marked variations, that could influence the findings 
of RP clinical trials (Figure 2). It is perhaps impossible to entirely mitigate the impact of weather 
when evaluating Raynaud’s but understanding its contribution can aid interpretation of study 
findings and help optimise clinical trial design.
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 Figure 1. Monthly UK Mean Temperature 2004-present (Degrees C)
Using UK Meterologiocal data available from [3]
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Figure 2. “If you don’t like the British weather, just wait 5 minutes”: Short-term marked 
variation in local weather could greatly influence Raynaud’s phenomenon clinical trial 
outcomes. 
2A, The University of Bath Campus 1st February 2019 (-2°C); 2B, the 27th February 2019 
(+16°C).
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